TROG0306_2: TROG0306, figure 2

TROG0306_2R Documentation

TROG0306, figure 2

Description

Kaplan-Meier digitized data from TROG0306, figure 2 (PMID 27155740). A reported sample size of 293 for a primary endpoint of OS in prostate cancer.

Usage

TROG0306_2

Format

A data frame of 293 observations and 3 variables:

time event time (in years)
event OS event indicator (0: no event, 1: event)
arm treatment arms (delayed_adt, immediate_adt)

Source

Duchesne GM, Woo HH, Bassett JK, et al. Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial. Lancet Oncol 2016; 17: 727–37.

Examples

summary(TROG0306_2)

kmplot(TROG0306_2)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.